Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

NCT05183854 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma

Interventions

BIOLOGICAL: Pneumococcal 20-valent Conjugate Vaccine
BIOLOGICAL: Pneumococcal Polyvalent Vaccine

Sponsor

University of Utah